WuXi AppTec Co., Ltd. (OTCMKTS:WUXAY – Get Free Report)’s share price gapped up before the market opened on Tuesday. The stock had previously closed at $25.98, but opened at $26.92. WuXi AppTec shares last traded at $26.92, with a volume of 241 shares.
Wall Street Analysts Forecast Growth
Separately, Zacks Research raised WuXi AppTec from a “hold” rating to a “strong-buy” rating in a research note on Friday, August 7th. One equities research analyst has rated the stock with a Strong Buy rating and one has given a Buy rating to the company. According to data from MarketBeat, WuXi AppTec currently has an average rating of “Strong Buy”.
Get Our Latest Stock Analysis on WuXi AppTec
WuXi AppTec Trading Up 2.2%
About WuXi AppTec
WuXi AppTec is a global pharmaceutical and biotechnology services company that provides research, development, and manufacturing support to pharmaceutical, biotechnology, and medical device companies. Its integrated platform is designed to help customers discover, develop, test, and manufacture medicines and healthcare products.
The company’s services include small-molecule drug discovery and development, laboratory testing, clinical research support, and pharmaceutical manufacturing. WuXi AppTec also provides capabilities in biologics, cell and gene therapies, medical devices, and other advanced therapeutic areas, serving customers across multiple stages of the product-development process.
Founded in 2000, WuXi AppTec is headquartered in Shanghai, China, and operates through a global network of research, testing, and manufacturing facilities in China, the United States, Europe, and other international markets.
Read More
- Five stocks we like better than WuXi AppTec
- Tesla’s Semi Is Finally Here—But Will It Move the Stock?
- 5 Stocks Showing Why Pricing Power Matters More Than Government Money
- Rocket Lab Bounces Off Its Lows—What’s Behind the Move?
- NVIDIA Just Turned AI Safety Into a Spending Story and These 3 Stocks Benefit
Receive News & Ratings for WuXi AppTec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for WuXi AppTec and related companies with MarketBeat.com's FREE daily email newsletter.
